CELLECTAR BIOSCIENCES INC

Historical 13F Holders

Symbol
CLRB
CUSIP
15117F880
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 15117F880 since 12/18/2024, newest first.

Filer % of Class Filed
Caligan Partners LP 13G
5.9% 8/14/2026
Event 6/30/2026
Balyasny Asset Management L.P. 13G
10.0% 8/14/2026
Event 6/30/2026
SilverArc Capital Management, LLC 13G
10.0% 8/14/2026
Event 6/30/2026
StemPoint Capital LP 13G
9.9% 8/14/2026
Event 6/30/2026
Bleichroeder LP 13G
10.0% 8/13/2026
Event 6/30/2026
Empery Asset Management, LP 13G
10.0% 8/4/2026
Event 6/30/2026
Janus Henderson Group PLC 13G 10.0% 6/5/2026
Event 5/29/2026
Stonepine Capital Management, LLC 13G
9.9% 5/11/2026
Event 5/4/2026
Bleichroeder LP 13G/A Amendment 1
4.6% 2/13/2026
Event 12/31/2025
Hexstone Capital LLC 13G/A Amendment 1
4.9% 2/4/2026
Event 12/31/2025
Bleichroeder LP 13G
6.1% 11/14/2025
Event 9/30/2025
Nantahala Capital Management, LLC 13G/A Amendment 3
0.1% 8/14/2025
Event 6/30/2025
Lytton Laurence W 13G/A Amendment 4 1.6% 8/14/2025
Event 6/30/2025
Hexstone Capital LLC 13G
5.6% 8/8/2025
Event 7/2/2025
Intracoastal Capital LLC 13G
4.99% 7/8/2025
Event 7/1/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 30 3.48 M $9.69 M
2026 Q1 19 311 k $813 k
2025 Q4 20 347 k $1.04 M
2025 Q3 21 296 k $1.65 M
2025 Q2 20 103 k $734 k